Shields Matthew sold TEVA
June 3, 2026 · Form 4 insider transaction
Shields Matthew sold 16,195 shares of Teva Pharmaceutical Industries Limited at $32.87 per share, a transaction worth $532.3K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Footnotes
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.; The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025.; Represents with respect to the vesting of restricted share units, the reporting person sold all such shares vested, including shares to cover tax witholding obligations in connection with the vesting.